상단영역
본문영역
ChongKunDang 목록 ( 총 : 17건)
기사목록 보기 형태
-
Novartis Korea Drives ESG Impact to the Heart of Society
이미지기사 제약 Sodam Park reporter 05.13 08:46 -
Toward a 0.01% Defect Rate: ChongKunDang’s AI-Led Quality Innovation
이미지기사 제약 Sodam Park reporter 05.09 04:49 -
종근당, 50여년만에 새 CI 내놔…현대적 감각 담아
이미지기사 제약 이우진 수석기자 05.07 17:30 -
Pharma Industry’s 2024 Earnings: Revenue Grow, Profits Decline
이미지기사 제약 Sodam Park reporter 02.19 05:04 -
South Korean Pharma Giants Eye Joint Sales for 'Ja Q Bo' Tablets
이미지기사 제약 Sodam Park reporter 2024.05.17 05:10 -
Jublia Generics Spark $23mn Nail Fungus Treatment Battle
이미지기사 제약 Sodam Park reporter 2024.04.30 05:59 -
Stormy Growth, Eroding Profit: 25 Years of Listed Pharmaceuticals
이미지기사 기획 Sodam Park reporter 2024.04.09 05:59 -
41 New Pharmaceuticals over $7.5mn: 25 South Korean, 16 Multinational
제약 Sodam Park reporter 2024.02.08 06:00 -
6 Promising New Drugs from Korean Pharma: Ready for Market
이미지기사 제약 Sodam Park reporter 2024.01.19 06:00 -
Top 7 Issues in Korean Pharma-Bio 2023
이미지기사 기획 Sodam Park reporter 2024.01.05 05:55 -
LegoChem Bio: $100mn Upfront Payment, $200mn Option Deal?
이미지기사 바이오 Sodam Park reporter 2023.12.31 09:59 -
DH Magic Strikes Again: $93mn K-CAB Deal with Boryung
이미지기사 제약 Sodam Park reporter 2023.12.15 05:47 -
ChongKunDang’s CKD-510: $1.35B Deal with Novartis
이미지기사 제약 Sodam Park reporter 2023.11.07 01:56 -
South Korean Firms Adopt Synaffix’s ADC Tech for Anticancer Drugs
이미지기사 바이오 Sodam Park reporter 2023.09.12 05:24 -
Amgen’s Psoriasis Patent Faces Setback in Pharma Dispute
이미지기사 제약 Sodam Park reporter 2023.08.31 05:20 -
ChongKunDang introduces Generic DPP-4 Inhibitor Diabetes Medication
이미지기사 제약 Sodam Park reporter 2023.08.24 05:21 -
Lixiana’s NCE Patent Worth $70 Million Broken after First Challenge in 5 Years
이미지기사 제약 Sodam Park reporter 2023.07.21 12:25